Status: current, Defined. Date: 30-Nov 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2135981000168112 | daratumumab 400 mg / 20 mL injection, 20 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2135991000168110 | daratumumab 400 mg/20 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| daratumumab 400 mg/20 mL injection, vial | Is a | daratumumab | true | Inferred relationship | Some | ||
| daratumumab 400 mg/20 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| daratumumab 400 mg/20 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| daratumumab 400 mg/20 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1662418221 | |
| daratumumab 400 mg/20 mL injection, vial | has Australian BoSS | daratumumab | true | Inferred relationship | Some | 1662418220 | |
| daratumumab 400 mg/20 mL injection, vial | has intended active ingredient | daratumumab | true | Inferred relationship | Some | 1662418220 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Darzalex (daratumumab 400 mg / 20 mL) injection, 20 mL vial (trade product unit of use) | Is a | True | daratumumab 400 mg/20 mL injection, vial | Inferred relationship | Some | |
| daratumumab 400 mg/20 mL injection, 20 mL vial | has MPUU | True | daratumumab 400 mg/20 mL injection, vial | Inferred relationship | Some | 1 |
| Daratumumab (Janssen) 400 mg/20 mL injection, 20 mL vial | Is a | True | daratumumab 400 mg/20 mL injection, vial | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set
FHIR